Jan 22, 2024
VPAG and Older Medicines The Department of Health and Social Care DHSC has for many years being receiving a rebate from the manufacturers of branded prescribed drugs. This is intended to keep a cap on the growth in the medicines bill whilst allowing manufacturers to...
Dec 6, 2023
WaveData’s MD, Charles Joynson looks at generic products sold in England, Scotland, Northern Ireland, and Wales, in August, September and October of this year, focusing in on the top 500 most commonly advertised products. We only included products which were...
Nov 30, 2023
Wavedata looked at the average prices of generic products sold to pharmacies and dispensing doctors between August and October 2023 and compared this with the number of price list offers for the same products in the same time period. It would seem sensible to assume...
Nov 22, 2023
The first generic versions of Zonisamide Caps 25mg 14 were launched after loss of exclusivity in November 2015. However, in the run-up to this, the prices being offered to pharmacists and dispensing doctors for the brand declined from about £8.00 to about £7.40. This...
Nov 20, 2023
Eplerenone Tabs were launched in September 2014 after the loss of exclusivity of Pfizer’s Inspra brand. Eplerenone is one of those products which is subject to regular price bounces, concessions and shortages. Each of the two packs has experienced three price bounces...
Nov 9, 2023
It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...
